Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 03/07: (XNCR) (LNCO) (URBN) Higher; (ACRX) (SHAK) (ILMN) Lower (more...)

March 7, 2016 6:03 PM
Xencor, Inc. (NASDAQ: XNCR) 30.4% HIGHER; announced dosing the first patient in a Phase 2 trial of XmAb®5871 in patients ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles